DNTT
Basic information
Region (hg38): 10:96304409-96338564
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (64 variants)
- not_provided (7 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNTT gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004088.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | |||||
| missense | 61 | 65 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 61 | 6 | 2 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DNTT | protein_coding | protein_coding | ENST00000371174 | 11 | 34237 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 2.95e-10 | 0.725 | 125654 | 1 | 90 | 125745 | 0.000362 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.466 | 314 | 292 | 1.08 | 0.0000165 | 3347 |
| Missense in Polyphen | 122 | 112.8 | 1.0816 | 1291 | ||
| Synonymous | -0.0165 | 107 | 107 | 1.00 | 0.00000614 | 943 |
| Loss of Function | 1.50 | 19 | 27.5 | 0.690 | 0.00000146 | 327 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000731 | 0.000731 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.000478 | 0.000475 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000330 | 0.000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells. {ECO:0000250|UniProtKB:P09838}.;
- Pathway
- Hematopoietic cell lineage - Homo sapiens (human);Non-homologous end-joining - Homo sapiens (human);Validated targets of C-MYC transcriptional repression;DNA-PK pathway in nonhomologous end joining
(Consensus)
Recessive Scores
- pRec
- 0.926
Intolerance Scores
- loftool
- 0.900
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 33.42
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- Y
- hipred_score
- 0.755
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.837
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dntt
- Phenotype
- homeostasis/metabolism phenotype; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); immune system phenotype;
Gene ontology
- Biological process
- DNA metabolic process;double-strand break repair via nonhomologous end joining;DNA modification;response to ATP;DNA biosynthetic process
- Cellular component
- nuclear chromatin;euchromatin;nucleus;nucleoplasm;cytosol;nuclear matrix
- Molecular function
- DNA binding;DNA-directed DNA polymerase activity;DNA nucleotidylexotransferase activity;protein binding;metal ion binding